CVE:TCI

Target Capital Stock Forecast, Price & News

C$0.02
+0.01 (+33.33 %)
(As of 11/5/2020)
Add
Compare
Today's Range
C$0.02
▼
C$0.02
50-Day Range
C$0.02
▼
C$0.02
52-Week Range
C$0.01
▼
C$0.03
Volume1.39 million shs
Average Volume154,952 shs
Market CapitalizationC$2.13 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TCI News and Ratings via Email

Sign-up to receive the latest news and ratings for Target Capital and its competitors with MarketBeat's FREE daily newsletter.


About Target Capital

Target Capital Inc. is a private equity and venture capital firm specializing in acquisitions, startups, early stage and buyout companies. It owns interests in future commissions on claims processed through the Olympia Trust Health Plan. It invests in listed public companies, trailer fee rights, notes receivable, reporting issuers, and controlled private companies. The firm also invests in land development corporations. It seeks to invest in medical and recreational cannabis industry, and in businesses offering from cultivators to ancillary supportive products and services. It prefers to invest in Canada, Europe and United States. It prefers to invest in companies that generate 10x ROI Within 3 Years. It prefers to take majority stake. It prefers to exit through acquisition. Target Capital Inc. was incorporated in 1993 and is headquartered in Calgary, Canada.

Headlines

Trains deal has messy endgame
Trains deal has messy endgame
September 16, 2021 |  reuters.com
CN Acknowledges TCI Announcement of Shareholder Meeting Requisition
CN Acknowledges TCI Announcement of Shareholder Meeting Requisition
September 15, 2021 |  au.finance.yahoo.com
Nifty may hit 17600 target this month, Bank Nifty looks set to touch 37700; Bharti Airtel, Kotak Bank top bets
Nifty may hit 17600 target this month, Bank Nifty looks set to touch 37700; Bharti Airtel, Kotak Bank top bets
September 13, 2021 |  msn.com
Screaming Buy! This Canadian Growth Stock Could Rally Soon
Screaming Buy! This Canadian Growth Stock Could Rally Soon
August 1, 2021 |  msn.com
Redburn Partners Initiates Coverage On AT&T with Sell Rating, Announces Price Target of $23
Redburn Partners Initiates Coverage On AT&T with Sell Rating, Announces Price Target of $23
June 27, 2021 |  benzinga.com
Chris Hohn tells Canadian National to drop $34bn Kansas City Southern bid
Chris Hohn tells Canadian National to drop $34bn Kansas City Southern bid
May 18, 2021 |  ft.com
Target Capital Announces Director and Officer Changes
Target Capital Announces Director and Officer Changes
April 16, 2021 |  markets.businessinsider.com
Money Making Opportunity | Stocks to buy with Anil Singhvi: Sandeep Jain recommends TCI Express today
Money Making Opportunity | Stocks to buy with Anil Singhvi: Sandeep Jain recommends TCI Express today
March 31, 2021 |  msn.com
Show us the plan: Investors push companies to come clean on climate
Show us the plan: Investors push companies to come clean on climate
February 24, 2021 |  msn.com
Freshpet, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results - MarketWatch
Freshpet, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results - MarketWatch
February 22, 2021 |  marketwatch.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.98 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Target Capital (CVE:TCI) Frequently Asked Questions

What stocks does MarketBeat like better than Target Capital?

Wall Street analysts have given Target Capital a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Target Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Target Capital's stock price been impacted by COVID-19 (Coronavirus)?

Target Capital's stock was trading at C$0.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TCI shares have increased by 0.0% and is now trading at C$0.02.
View which stocks have been most impacted by COVID-19.

Who are Target Capital's key executives?

Target Capital's management team includes the following people:
  • Mr. Shahin Mottahed, Chairman, Pres & CEO
  • Colin Wagner, Chief Financial Officer
  • Mr. Jason Kujath, Gen. Counsel (Age 36)
  • Mr. Sanjib Singh Gill L.L.B., Corp. Sec. (Age 45)

Who are some of Target Capital's key competitors?

Some companies that are related to Target Capital include Limitless Earth (LME), Tetragon Financial Group (TFG), Esstra Industries (ESS), Artemis VCT PLC Fund O Inc (AAM.L) (AAM), Downing FOUR VCT (DO1D), Faircourt Gold Income (FGX), KRM22 (KRM), Argo Group (ARGO), British & American Investment Trust (BAF), Blue Star Capital (BLU), SVM UK Emerging Fund (SVM), Sure Ventures (SURE), Two Shields Investments Plc (TSI.L) (TSI), Downing Three VCT Plc 'J' (DP3J) and Infrastructure India (IIP).
View all of TCI's competitors.

What other stocks do shareholders of Target Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Target Capital investors own include Cloudera (CLDR), Glacier Bancorp (GBCI), Giga-tronics (GIGA), InterDigital (IDCC), PepsiCo (PEP), Parkland (PKI), Sienna Senior Living (SIA), Terex (TEX), Galiano Gold (AKG) and Aguia Resources (AGRL).

What is Target Capital's stock symbol?

Target Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "TCI."

How do I buy shares of Target Capital?

Shares of TCI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Target Capital's stock price today?

One share of TCI stock can currently be purchased for approximately C$0.02.

How much money does Target Capital make?

Target Capital has a market capitalization of C$2.13 million and generates C$774,566.00 in revenue each year.

What is Target Capital's official website?

The official website for Target Capital is www.targetcapitalinc.com.

How can I contact Target Capital?

The company can be reached via phone at 403-351-1779.


This page was last updated on 9/17/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.